{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T09:44:30Z","timestamp":1787823870987,"version":"build-2784847793"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,2]]},"DOI":"10.7759\/cureus.38431","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T12:13:17Z","timestamp":1683029597000},"source":"Crossref","is-referenced-by-count":1,"title":["Antibiotics-Related Adverse Drug Reaction in a Tertiary Hospital in Saudi Arabia: A Cohort, Retrospective Study"],"prefix":"10.7759","author":[{"given":"Hanan","family":"Ahmed Bakri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz A","family":"Jaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/IPRP.S105881","article-title":"Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting","volume":"6","author":"Hadi MA","year":"2017","unstructured":"Hadi MA, Neoh CF, Zin RM, Elrggal ME, Cheema E. Pharmacovigilance: pharmacists' perspective on spontaneous adverse drug reaction reporting. Integr Pharm Res Pract. 2017, 6:91-8. 10.2147\/IPRP.S105881","journal-title":"Integr Pharm Res Pract"},{"key":"ref2","article-title":"Safety of Medicines - Adverse Drug Reactions","author":"World Health Organization","year":"2002","unstructured":"World Health Organization. Safety of Medicines - Adverse Drug Reactions. World Health Organization, Geneva; 2002."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","author":"Davies EC","year":"2009","unstructured":"Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009, 4:e4439. 10.1371\/journal.pone.0004439","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/00140130500101247","article-title":"Ageing and activity: their effects on the functional reserve capacities of the heart and vascular smooth and skeletal muscles","volume":"48","author":"Goldspink DF","year":"2005","unstructured":"Goldspink DF. Ageing and activity: their effects on the functional reserve capacities of the heart and vascular smooth and skeletal muscles. Ergonomics. 2005, 48:1334-51. 10.1080\/00140130500101247","journal-title":"Ergonomics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7265","article-title":"Global incidence and mortality trends due to adverse effects of medical treatment, 1990-2017: a systematic analysis from the Global Burden of Diseases, Injuries and Risk Factors Study","volume":"12","author":"Nauman J","year":"2020","unstructured":"Nauman J, Soteriades ES, Hashim MJ, et al.. Global incidence and mortality trends due to adverse effects of medical treatment, 1990-2017: a systematic analysis from the Global Burden of Diseases, Injuries and Risk Factors Study. Cureus. 2020, 12:e7265. 10.7759\/cureus.7265","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252161","article-title":"Prevalence of adverse drug reactions in the primary care setting: a systematic review and meta-analysis","volume":"16","author":"Insani WN","year":"2021","unstructured":"Insani WN, Whittlesea C, Alwafi H, Man KK, Chapman S, Wei L. Prevalence of adverse drug reactions in the primary care setting: a systematic review and meta-analysis. PLoS One. 2021, 16:e0252161. 10.1371\/journal.pone.0252161","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010831","article-title":"Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study","volume":"6","author":"Aljadhey H","year":"2016","unstructured":"Aljadhey H, Mahmoud MA, Ahmed Y, et al.. Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study. BMJ Open. 2016, 6:e010831. 10.1136\/bmjopen-2015-010831","journal-title":"BMJ Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19010254","article-title":"Antimicrobial usage and resistance in Makkah region hospitals: a regional point prevalence survey of public hospitals","volume":"19","author":"Haseeb A","year":"2021","unstructured":"Haseeb A, Faidah HS, Algethamy M, et al.. Antimicrobial usage and resistance in Makkah region hospitals: a regional point prevalence survey of public hospitals. Int J Environ Res Public Health. 2021, 19:146. 10.3390\/ijerph19010254","journal-title":"Int J Environ Res Public Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma PD","year":"2017","unstructured":"Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017, 177:1308-15. 10.1001\/jamainternmed.2017.1938","journal-title":"JAMA Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4304973","article-title":"Antibiotic-related adverse drug reactions at a tertiary care hospital in South Korea","volume":"2017","author":"Jung IY","year":"2017","unstructured":"Jung IY, Kim JJ, Lee SJ, et al.. Antibiotic-related adverse drug reactions at a tertiary care hospital in South Korea. Biomed Res Int. 2017, 2017:4304973. 10.1155\/2017\/4304973","journal-title":"Biomed Res Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.298","article-title":"Antibiotic-associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study","volume":"5","author":"Kiguba R","year":"2017","unstructured":"Kiguba R, Karamagi C, Bird SM. Antibiotic-associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study. Pharmacol Res Perspect. 2017, 5:e00298. 10.1002\/prp2.298","journal-title":"Pharmacol Res Perspect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2016.04.011","article-title":"Frequency, types, severity, preventability and costs of adverse drug reactions at a tertiary care hospital","volume":"81","author":"Geer MI","year":"2016","unstructured":"Geer MI, Koul PA, Tanki SA, Shah MY. Frequency, types, severity, preventability and costs of adverse drug reactions at a tertiary care hospital. J Pharmacol Toxicol Methods. 2016, 81:323-34. 10.1016\/j.vascn.2016.04.011","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis","volume":"135","author":"Macy E","year":"2015","unstructured":"Macy E, Contreras R. Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis. J Allergy Clin Immunol. 2015, 135:745-52.e5. 10.1016\/j.jaci.2014.07.062","journal-title":"J Allergy Clin Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03655.x","article-title":"Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury","volume":"27","author":"Garc\u00eda-Cort\u00e9s M","year":"2008","unstructured":"Garc\u00eda-Cort\u00e9s M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther. 2008, 27:780-9. 10.1111\/j.1365-2036.2008.03655.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref15","article-title":"Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital","volume":"33","author":"Khan LM","year":"2012","unstructured":"Khan LM, Al-Harthi SE, Saadah OI, Al-Amoudi AB, Sulaiman MI, Ibrahim IM. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital. Saudi Med J. 2012, 33:863-8.","journal-title":"Saudi Med J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2022.03.018","article-title":"The evaluation of adverse drug reactions in Saudi Arabia: a retrospective observational study","volume":"30","author":"Alenzi KA","year":"2022","unstructured":"Alenzi KA, Alanazi NS, Almalki M, Alomrani H, Alatawi FO. The evaluation of adverse drug reactions in Saudi Arabia: a retrospective observational study. Saudi Pharm J. 2022, 30:735-41. 10.1016\/j.jsps.2022.03.018","journal-title":"Saudi Pharm J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030624","article-title":"Reporting antimicrobial-related adverse drug events in Jordan: an analysis from the VigiBase database","volume":"12","author":"Mhaidat NM","year":"2023","unstructured":"Mhaidat NM, Al-Azzam S, Banat HA, Jaber JM, Araydah M, Alshogran OY, Aldeyab MA. Reporting antimicrobial-related adverse drug events in Jordan: an analysis from the VigiBase database. Antibiotics (Basel). 2023, 12:624. 10.3390\/antibiotics12030624","journal-title":"Antibiotics (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00809","article-title":"Evaluation of reported adverse drug reactions in antibiotic usage: a retrospective study from a tertiary care hospital, Malaysia","volume":"9","author":"Arulappen AL","year":"2018","unstructured":"Arulappen AL, Danial M, Sulaiman SA. Evaluation of reported adverse drug reactions in antibiotic usage: a retrospective study from a tertiary care hospital, Malaysia. Front Pharmacol. 2018, 9:809. 10.3389\/fphar.2018.00809","journal-title":"Front Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-020-0402-x","article-title":"Antibiotic hypersensitivity and adverse reactions: management and implications in clinical practice","volume":"16","author":"Jourdan A","year":"2020","unstructured":"Jourdan A, Sangha B, Kim E, Nawaz S, Malik V, Vij R, Sekhsaria S. Antibiotic hypersensitivity and adverse reactions: management and implications in clinical practice. Allergy Asthma Clin Immunol. 2020, 16:6. 10.1186\/s13223-020-0402-x","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.06.017","article-title":"The 3 CS of antibiotic allergy-classification, cross-reactivity, and collaboration","volume":"5","author":"Trubiano JA","year":"2017","unstructured":"Trubiano JA, Stone CA, Grayson ML, Urbancic K, Slavin MA, Thursky KA, Phillips EJ. The 3 CS of antibiotic allergy-classification, cross-reactivity, and collaboration. J Allergy Clin Immunol Pract. 2017, 5:1532-42. 10.1016\/j.jaip.2017.06.017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/01.all.0000173788.73401","article-title":"Cephalosporin chemical reactivity and its immunological implications","volume":"5","author":"Perez-Inestrosa E","year":"2005","unstructured":"Perez-Inestrosa E, Suau R, Monta\u00f1ez MI, et al.. Cephalosporin chemical reactivity and its immunological implications. Curr Opin Allergy Clin Immunol. 2005, 5:323-30. 10.1097\/01.all.0000173788.73401","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.06.001","article-title":"Cephalosporin allergy: current understanding and future challenges","volume":"7","author":"Khan DA","year":"2019","unstructured":"Khan DA, Banerji A, Bernstein JA, et al.. Cephalosporin allergy: current understanding and future challenges. J Allergy Clin Immunol Pract. 2019, 7:2105-14. 10.1016\/j.jaip.2019.06.001","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2015.7.11751","article-title":"Completeness of adverse drug reactions reports of the Saudi adverse event reporting system","volume":"36","author":"Alshammari TM","year":"2015","unstructured":"Alshammari TM, Al-Kathiri WH, Le Louet H, Aljadhey HS. Completeness of adverse drug reactions reports of the Saudi adverse event reporting system. Saudi Med J. 2015, 36:821-8. 10.15537\/smj.2015.7.11751","journal-title":"Saudi Med J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102060-00001","article-title":"Do women have more adverse drug reactions?","volume":"2","author":"Rademaker M","year":"2001","unstructured":"Rademaker M. Do women have more adverse drug reactions?. Am J Clin Dermatol. 2001, 2:349-51. 10.2165\/00128071-200102060-00001","journal-title":"Am J Clin Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4155","article-title":"Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden","volume":"26","author":"Holm L","year":"2017","unstructured":"Holm L, Ekman E, Jors\u00e4ter Blomgren K. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2017, 26:335-43. 10.1002\/pds.4155","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/153540-antibiotics-related-adverse-drug-reaction-in-a-tertiary-hospital-in-saudi-arabia-a-cohort-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:12Z","timestamp":1707508692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/153540-antibiotics-related-adverse-drug-reaction-in-a-tertiary-hospital-in-saudi-arabia-a-cohort-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.38431","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,2]]}}}